BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 24651474)

  • 1. Diagnostic and prognostic implications of a serum miRNA panel in oesophageal squamous cell carcinoma.
    Wu C; Wang C; Guan X; Liu Y; Li D; Zhou X; Zhang Y; Chen X; Wang J; Zen K; Zhang CY; Zhang C
    PLoS One; 2014; 9(3):e92292. PubMed ID: 24651474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel serum microRNA signature to screen esophageal squamous cell carcinoma.
    Huang Z; Zhang L; Zhu D; Shan X; Zhou X; Qi LW; Wu L; Zhu J; Cheng W; Zhang H; Chen Y; Zhu W; Wang T; Liu P
    Cancer Med; 2017 Jan; 6(1):109-119. PubMed ID: 28035762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.
    Guan S; Wang C; Chen X; Liu B; Tan B; Liu F; Wang D; Han L; Wang L; Huang X; Wang J; Yao B; Shi J; Chen P; Nesa EU; Song Q; Cheng Y
    Tumour Biol; 2016 Apr; 37(4):4383-91. PubMed ID: 26499784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma.
    Zhang C; Wang C; Chen X; Yang C; Li K; Wang J; Dai J; Hu Z; Zhou X; Chen L; Zhang Y; Li Y; Qiu H; Xing J; Liang Z; Ren B; Yang C; Zen K; Zhang CY
    Clin Chem; 2010 Dec; 56(12):1871-9. PubMed ID: 20943850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
    Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
    Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and diagnostic potential of miR-146a in oesophageal squamous cell carcinoma.
    Wang C; Guan S; Liu F; Chen X; Han L; Wang D; Nesa EU; Wang X; Bao C; Wang N; Cheng Y
    Br J Cancer; 2016 Feb; 114(3):290-7. PubMed ID: 26794279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma.
    Cui Y; Xue Y; Dong S; Zhang P
    J Int Med Res; 2017 Aug; 45(4):1310-1317. PubMed ID: 28587538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of plasma miRNA-718 for esophageal squamous cell carcinoma.
    Sun L; Dong S; Dong C; Sun K; Meng W; Lv P; Yin H; Ming L; He F
    Cancer Biomark; 2016; 16(2):265-73. PubMed ID: 26756617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-367 is a potential diagnostic biomarker for patients with esophageal squamous cell carcinoma.
    Sun J; Song K; Feng X; Gao S
    Biochem Biophys Res Commun; 2016 Apr; 473(2):363-9. PubMed ID: 26777997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma.
    Komatsu S; Ichikawa D; Takeshita H; Tsujiura M; Morimura R; Nagata H; Kosuga T; Iitaka D; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Otsuji E
    Br J Cancer; 2011 Jun; 105(1):104-11. PubMed ID: 21673684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum microRNA-15a level acts as a potential diagnostic and prognostic biomarker for human esophageal squamous cell carcinoma.
    Li J; Li M; Gao F; Ge X
    Cancer Biomark; 2017; 18(1):11-17. PubMed ID: 27802201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma.
    Zhou X; Wen W; Zhu J; Huang Z; Zhang L; Zhang H; Qi LW; Shan X; Wang T; Cheng W; Zhu D; Yin Y; Chen Y; Zhu W; Shu Y; Liu P
    Oncotarget; 2017 May; 8(21):34468-34480. PubMed ID: 28380431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma.
    Wu C; Li M; Hu C; Duan H
    Mol Biol Rep; 2014 Mar; 41(3):1257-66. PubMed ID: 24390317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma.
    Takeshita N; Hoshino I; Mori M; Akutsu Y; Hanari N; Yoneyama Y; Ikeda N; Isozaki Y; Maruyama T; Akanuma N; Komatsu A; Jitsukawa M; Matsubara H
    Br J Cancer; 2013 Feb; 108(3):644-52. PubMed ID: 23361059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
    Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
    Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.
    Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY
    J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
    Wang WT; Guo CQ; Cui GH; Zhao S
    World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma miRNA-506 as a Prognostic Biomarker for Esophageal Squamous Cell Carcinoma.
    Li SP; Su HX; Zhao D; Guan QL
    Med Sci Monit; 2016 Jun; 22():2195-201. PubMed ID: 27345473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of microRNA 574-3p as a predictor of postoperative outcome in patients with esophageal squamous cell carcinoma.
    Okumura T; Kojima H; Miwa T; Sekine S; Hashimoto I; Hojo S; Nagata T; Shimada Y
    World J Surg Oncol; 2016 Aug; 14(1):228. PubMed ID: 27565418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma.
    Hirajima S; Komatsu S; Ichikawa D; Takeshita H; Konishi H; Shiozaki A; Morimura R; Tsujiura M; Nagata H; Kawaguchi T; Arita T; Kubota T; Fujiwara H; Okamoto K; Otsuji E
    Br J Cancer; 2013 May; 108(9):1822-9. PubMed ID: 23579215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.